MA31635B1 - Dérivés de 1-oxo-isoindoline-4-carboxamides et de 1-oxo-1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur préparation et leur application en thérapeutique - Google Patents
Dérivés de 1-oxo-isoindoline-4-carboxamides et de 1-oxo-1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur préparation et leur application en thérapeutiqueInfo
- Publication number
- MA31635B1 MA31635B1 MA32652A MA32652A MA31635B1 MA 31635 B1 MA31635 B1 MA 31635B1 MA 32652 A MA32652 A MA 32652A MA 32652 A MA32652 A MA 32652A MA 31635 B1 MA31635 B1 MA 31635B1
- Authority
- MA
- Morocco
- Prior art keywords
- group
- alkyl
- oxo
- cycloalkyl
- atom
- Prior art date
Links
- SYNWVHZFMKIQRS-UHFFFAOYSA-N 1-oxo-2,3-dihydroisoindole-4-carboxamide Chemical compound NC(=O)C1=CC=CC2=C1CNC2=O SYNWVHZFMKIQRS-UHFFFAOYSA-N 0.000 title abstract 2
- ZLCXKZGIKAWAQY-UHFFFAOYSA-N 1-oxo-3,4-dihydro-2h-isoquinoline-5-carboxamide Chemical class O=C1NCCC2=C1C=CC=C2C(=O)N ZLCXKZGIKAWAQY-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 9
- 125000005843 halogen group Chemical group 0.000 abstract 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- -1 nitro, cyano, amino Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 239000002439 beta secretase inhibitor Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
L'invention concerne les dérivés de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tétrahydroisoquinoléine-5-carboxamides, de formule générale (i) dans laquelle r1 représente un atome d'hydrogène, un groupe (c1-c6)alkyle, (c3-c7)cycloalkyle (ch2)n-(c1-c6)alcényle, (ch2)n-(c1-c6)alcynyle, (c1-c6)alkyle-z-(c1-c6)alkyle dans lequel z représente un hétéroatome choisi parmi o, n et s(o)m, ou bien r1 représente u groupe coor, s(o)mr, un aryle ou un aralkyle; r2 représente un ou plusieurs groupe choisis parmi un atome d'hydrogène, un atome d'halogène, un groupe (c1-c6)alkyle, (c3- c7)cycloalkyle,.(c1-c6)alcényle, (c1-c6)alcynyle, (c1-c6)alkyle-z-(c1-c6)alky!E, dans lequel z représente un hétéroatome choisi parmi o, n et s(o)m, ou bien r2 représente u groupe halo(c1-c6)alkyle, halo(c1-c6)alcoxy, hydroxy, (c1-c6)alcoxy, nitro, cyano, amino un groupe nr7r8, coor, conr7r8, oco(c1-c6)alkyle, s(o)mnr7r8, un groupe aryle r3 représente un groupe trifluorométhyle; r4 et r5 représentent, indépendamment l'un d l'autre, un atome d'hydrogène, ou bien r4 et r5 forment avec l'atome de carbone qui le porte un cycle saturé contenant de 3 à 6 atomes de carbone et contenant éventuellement de o à 1 hétéroatome choisis parmi o, n ou s; r6 représente un groupe choisi parmi u atome d'hydrogène, un atome d'halogène, un groupe (c1-c6)alkyle, (c3-c7)cycloalkyle (c3-c7)cycloalkyle(c1-c6)alkyle, un groupe halo(c1-c6)alkyle, nitro, amino, un group nr7r8, coor, un groupe nr7(so2)r8, conr7r8, un groupe aryle ou hétérocycle; représente un groupe (c1-c2)alkylène; m représente un nombre entier compris entre o et 2 n représente un nombre entier compris entre 1 et 6. L'invention a également trait à leur procédé de préparation et leur application e thérapeutique comme inhibiteurs de ß-secrétase pour traiter les trouble neurodégénératifs tels qu'alzheimer. I
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0705499A FR2919285B1 (fr) | 2007-07-27 | 2007-07-27 | Derives de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur preparation et leur application en therapeutique. |
| PCT/FR2008/001110 WO2009044019A2 (fr) | 2007-07-27 | 2008-07-25 | Dérivés de 1-oxo-isoindoline-4-carboxamides et de 1-oxo-1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur préparation et leur application en thérapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA31635B1 true MA31635B1 (fr) | 2010-08-02 |
Family
ID=39092246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA32652A MA31635B1 (fr) | 2007-07-27 | 2010-02-24 | Dérivés de 1-oxo-isoindoline-4-carboxamides et de 1-oxo-1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur préparation et leur application en thérapeutique |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8372864B2 (fr) |
| EP (1) | EP2185511A2 (fr) |
| JP (1) | JP5412428B2 (fr) |
| KR (1) | KR20100051830A (fr) |
| CN (1) | CN101790514B (fr) |
| AU (1) | AU2008306763B2 (fr) |
| BR (1) | BRPI0813624A2 (fr) |
| CA (1) | CA2694322A1 (fr) |
| CO (1) | CO6290678A2 (fr) |
| EA (1) | EA201070197A1 (fr) |
| FR (1) | FR2919285B1 (fr) |
| MA (1) | MA31635B1 (fr) |
| MX (1) | MX2010001079A (fr) |
| MY (1) | MY150436A (fr) |
| NZ (1) | NZ582873A (fr) |
| SG (1) | SG183082A1 (fr) |
| WO (1) | WO2009044019A2 (fr) |
| ZA (1) | ZA201000582B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014520776A (ja) | 2011-07-04 | 2014-08-25 | バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー | 植物における非生物的ストレスに対する活性薬剤としての置換されているイソキノリノン類、イソキノリンジオン類、イソキノリントリオン類およびジヒドロイソキノリノン類または各場合でのそれらの塩の使用 |
| CN105254554B (zh) * | 2014-07-14 | 2018-01-30 | 南开大学 | 一种制备异吲哚啉酮类化合物的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0846112A1 (fr) * | 1995-08-25 | 1998-06-10 | E.I. Du Pont De Nemours And Company | Herbicides bicycliques |
| DE10018449A1 (de) | 2000-04-14 | 2001-11-22 | Top Caredent Ag Zuerich | Vorrichtung zum Darbieten von Gerätschaften der Dentalhygiene |
| IL161881A0 (en) * | 2001-11-08 | 2005-11-20 | Upjohn Co | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| GB0228410D0 (en) * | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
| GB0305918D0 (en) * | 2003-03-14 | 2003-04-23 | Glaxo Group Ltd | Novel compounds |
| GB0309221D0 (en) | 2003-04-23 | 2003-06-04 | Glaxo Group Ltd | Novel compounds |
| GB0328900D0 (en) | 2003-12-12 | 2004-01-14 | Glaxo Group Ltd | Novel compounds |
| US7745470B2 (en) | 2005-03-10 | 2010-06-29 | Bristol-Myers Squibb Company | Isophthalates as beta-secretase inhibitors |
| GB0506562D0 (en) | 2005-03-31 | 2005-05-04 | Glaxo Group Ltd | Novel compounds |
| FR2919286A1 (fr) * | 2007-07-27 | 2009-01-30 | Sanofi Aventis Sa | Derives de derives de 1-oxo-1,2-dihydroisoquinoleine-5- carboxamides et de 4-oxo-3,4-dihydroquinazoline-8- carboxamides,leur preparation et leur application en therapeutique. |
| RS51912B (sr) * | 2007-07-27 | 2012-02-29 | Sanofi | DERIVATI 1,2,3,4-TETRAHIDROPIROLO(1,2-a)PIRAZIN-6-KARBOKSAMIDA I 2,3,4,5-TETRAHIDROPIROLO(1,2-a)(1,4)-DIAZEPIN-7-KARBOKSAMIDA NJIHOVO DOBIJANJE I TERAPEUTSKA PRIMENA |
-
2007
- 2007-07-27 FR FR0705499A patent/FR2919285B1/fr not_active Expired - Fee Related
-
2008
- 2008-07-25 CN CN2008801045290A patent/CN101790514B/zh not_active Expired - Fee Related
- 2008-07-25 WO PCT/FR2008/001110 patent/WO2009044019A2/fr not_active Ceased
- 2008-07-25 NZ NZ582873A patent/NZ582873A/en not_active IP Right Cessation
- 2008-07-25 CA CA2694322A patent/CA2694322A1/fr not_active Abandoned
- 2008-07-25 JP JP2010517453A patent/JP5412428B2/ja not_active Expired - Fee Related
- 2008-07-25 AU AU2008306763A patent/AU2008306763B2/en not_active Ceased
- 2008-07-25 MX MX2010001079A patent/MX2010001079A/es active IP Right Grant
- 2008-07-25 EP EP08835551A patent/EP2185511A2/fr not_active Ceased
- 2008-07-25 KR KR1020107004339A patent/KR20100051830A/ko not_active Ceased
- 2008-07-25 MY MYPI20100428 patent/MY150436A/en unknown
- 2008-07-25 SG SG2012055539A patent/SG183082A1/en unknown
- 2008-07-25 EA EA201070197A patent/EA201070197A1/ru unknown
- 2008-07-25 BR BRPI0813624A patent/BRPI0813624A2/pt not_active IP Right Cessation
-
2010
- 2010-01-26 US US12/693,597 patent/US8372864B2/en not_active Expired - Fee Related
- 2010-01-26 ZA ZA2010/00582A patent/ZA201000582B/en unknown
- 2010-01-26 CO CO10007698A patent/CO6290678A2/es not_active Application Discontinuation
- 2010-02-24 MA MA32652A patent/MA31635B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY150436A (en) | 2014-01-30 |
| EP2185511A2 (fr) | 2010-05-19 |
| WO2009044019A3 (fr) | 2009-06-18 |
| AU2008306763A1 (en) | 2009-04-09 |
| CN101790514A (zh) | 2010-07-28 |
| JP5412428B2 (ja) | 2014-02-12 |
| KR20100051830A (ko) | 2010-05-18 |
| BRPI0813624A2 (pt) | 2019-09-24 |
| US20100197725A1 (en) | 2010-08-05 |
| WO2009044019A9 (fr) | 2010-10-14 |
| AU2008306763B2 (en) | 2013-08-29 |
| CA2694322A1 (fr) | 2009-04-09 |
| FR2919285A1 (fr) | 2009-01-30 |
| WO2009044019A2 (fr) | 2009-04-09 |
| SG183082A1 (en) | 2012-08-30 |
| HK1143163A1 (en) | 2010-12-24 |
| CO6290678A2 (es) | 2011-06-20 |
| CN101790514B (zh) | 2012-12-19 |
| NZ582873A (en) | 2012-07-27 |
| US8372864B2 (en) | 2013-02-12 |
| JP2010534641A (ja) | 2010-11-11 |
| MX2010001079A (es) | 2010-03-24 |
| EA201070197A1 (ru) | 2010-08-30 |
| ZA201000582B (en) | 2011-04-28 |
| FR2919285B1 (fr) | 2012-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA31629B1 (fr) | Dérivés de 1-0x0-1,2-dihydroisoquinoleine-5-carboxamides et de 4-oxo-3,4-dihydroquinazoline-8-carboxamides, leur préparation et leur application en thérapeutique | |
| CA2662848C (fr) | Derives de 2-aryl-6-phenyl-imidazo[1,2-.alpha.]pyridines, leur preparation et leur application en therapeutique | |
| EA200200716A1 (ru) | Арилконденсированные азаполициклические соединения | |
| MA31373B1 (fr) | Composes amino-heterocycliques | |
| MA27079A1 (fr) | Derives 1, 6-naphthyridine et leur utilisation dans le traitement du diabete et de troubles associes | |
| KR970059163A (ko) | 할로겐기가 치환된 2-페닐-1, 2-에탄디올 카바메이트 화합물 | |
| HUP0303281A2 (hu) | Benzodiazepinszármazékok, mint GABA A receptor modulátorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| SE0104334D0 (sv) | Therapeutic agents | |
| MA31865B1 (fr) | Dérivés isoxazolo-pyridine | |
| RU2008119842A (ru) | Производные триазола в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы-1 | |
| MA30695B1 (fr) | Derives de n-(amino-heteroaryl)-1h-indole -2-carboxamides, leur preparation et leur application en therapeutique. | |
| CA2092794A1 (fr) | Naphtylalkylamines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA30167B1 (fr) | Nouveaux composes | |
| MA30315B1 (fr) | Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EA200870577A1 (ru) | Конденсированные трициклические сульфонамидные ингибиторы гамма-секретазы | |
| TNSN07041A1 (fr) | Derives de n-(1 h-indolyl)-i h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
| RU2219179C2 (ru) | Азациклические соединения, фармацевтические композиции | |
| NZ336623A (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines for use in the treatment and prevention of disorders of the central nervous system | |
| MA31742B1 (fr) | Derives de l'indol-2-one disubstitues en 3, leur preparation et leur application en therapeutique | |
| TW200700069A (en) | Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives | |
| RU2010107603A (ru) | Производные n-(2-тиазолил)амида для лечения ожирения, диабетов и сердечно-сосудистых заболеваний | |
| TNSN04234A1 (fr) | Derives de n-acylaminobenzene comme inhibiteurs selectifs de la monoamine oxydase b | |
| DE69705035D1 (de) | N-Azacycloalkylalkyldibenzothiophencarboxamide: spezifische Liganden für Dopaminrezeptorsubtypen | |
| TNSN07335A1 (fr) | Derives de 1, 2, 4-triazines, leur preparation et leur application en therapeutique humaine | |
| HUP0203526A2 (hu) | D4-antagonistákként alkalmazható tienoizoxazolil- és tienilpirazolil-fenoxi-helyettesített propilszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |